Metastatic tumors to the pancreas: The role of surgery

Table 3 Pancreatic resections for metastatic melanoma

Ref.	Year	No	Interval (Yr)	Primary site	Surgery	Follow-up (mo)	Outcome
Dasgupta et al[77]	1964	1	2	Skin	DP + duodenal resection	10	DOD
Johansson et al[78]	1970	1	12	Ocular	PD	11	ANED
Lasser et al[79]	1990	1	8	Skin	PD	10	ANED
Bianca et al[80]	1991	1	NA	NA	PD	12	AWD
Brodish et al[81]	1993	1	34	Skin	DP	8	AWD
Harrison et al[58]	1997	1	NR	NA	PD	108	ANED
Medina-Franco et al[82]	1999	1	NA	NA	PPPD	6	DOD
Wood et al[74]	2001	8	NA	NA	PD	37.5%1	DOD
Hiotis et al[83]	2002	1	NR	NR	PD	NR	DOD
Camp et al[84]	2002	1	6	Ocular	DP	20	ANED
Nikfarjam et al[85]	2003	2	12, 13	Ocular	PPPD, TP	6, 7	ANED
Carboni et al[86]	2004	1	9	Skin	PD	4	DOD
Crippa et al[24]	2006	1	2.8	Skin	PPPD	14	DOD
Belágyi et al[87]	2006	1	6	Skin	Enucleation	4	DOD
Edit et al[37]	2007	4	3, 4, 4, 14	NA	PPPD (4)	12, 25 30, 76	DOD ANED
Vagefi et al[88]	2009	1	28	Ocular	DP	NR	NR
Sperti et al[89]	2009	1	3	NA	DP	24	DOD
He et al[90]	2010	1	5	Ocular	DP	25	ANED
Lanitis et al[91]	2010	1	5	Skin	PD	96	ANED
Moszkowicz et al[92]	2011	1	15	Skin	PD	NA	NA
Portale et al[93]	2011	1	7	Skin	DP	NA	ANED
Goyal et al[94]	2012	5	3, 22, ?, 5, ?	Skin (3), NA (2)	PPPD (4),DP(1)	15, 3, 11.4, 4.5, 25	DOD
Sugimoto et al[95]	2013	1	1	Nasal	DP	10	DOD
Total		38	6 (median)	Skin = 12; Ocular = 6; Nasal = 1; NA = 18; NR = 1	PD (16), DP (9), PPPD (11), TP (1), Enucleation (1)	11, 7 (median)

¹5 years survival rate. NR: Not reported; NA: Not available; DP: Distal pancreatectomy; PD: Pancreaticoduodenectomy; PPPD: Pylorus-preserving pancreaticoduodenectomy; MSPP: Middle-segment-preserving pancreatectomy; SMV: Superior mesenteric vein; DOD: Dead of disease; ANED: Alive not evidence of disease; AWD: Alive with disease.